187 related articles for article (PubMed ID: 25117628)
1. Defining the recognition elements of Lewis Y-reactive antibodies.
Saha S; Pashov A; Siegel ER; Murali R; Kieber-Emmons T
PLoS One; 2014; 9(8):e104208. PubMed ID: 25117628
[TBL] [Abstract][Full Text] [Related]
2. A molecular basis for functional peptide mimicry of a carbohydrate antigen.
Luo P; Canziani G; Cunto-Amesty G; Kieber-Emmons T
J Biol Chem; 2000 May; 275(21):16146-54. PubMed ID: 10748116
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
Murali R; Kieber-Emmons T
J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
[TBL] [Abstract][Full Text] [Related]
4. Human germline antibody gene segments encode polyspecific antibodies.
Willis JR; Briney BS; DeLuca SL; Crowe JE; Meiler J
PLoS Comput Biol; 2013 Apr; 9(4):e1003045. PubMed ID: 23637590
[TBL] [Abstract][Full Text] [Related]
5. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens.
Luo P; Agadjanyan M; Qiu J; Westerink MA; Steplewski Z; Kieber-Emmons T
Mol Immunol; 1998 Sep; 35(13):865-79. PubMed ID: 9839555
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
Ruff-Jamison S; Glenney JR
Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
[TBL] [Abstract][Full Text] [Related]
7. Modeling study of antibody combining sites to (alpha 1-6)dextrans. Predictions of the conformational contribution of VL-CDR3 and J kappa segments to groove-type combining sites.
Wang D; Hubbard JM; Kabat EA
J Biol Chem; 1993 Sep; 268(27):20584-9. PubMed ID: 7690758
[TBL] [Abstract][Full Text] [Related]
8. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
[TBL] [Abstract][Full Text] [Related]
9. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms.
Monteiro MA; Chan KH; Rasko DA; Taylor DE; Zheng PY; Appelmelk BJ; Wirth HP; Yang M; Blaser MJ; Hynes SO; Moran AP; Perry MB
J Biol Chem; 1998 May; 273(19):11533-43. PubMed ID: 9565568
[TBL] [Abstract][Full Text] [Related]
11. Lea-active heptaglycosylceramide, a hybrid of type 1 and type 2 chain, and the pattern of glycolipids with Lea, Leb, X (Lex), and Y (Ley) determinants in human blood cell membranes (ghosts). Evidence that type 2 chain can elongate repetitively but type 1 chain cannot.
Kannagi R; Levery SB; Hakomori S
J Biol Chem; 1985 May; 260(10):6410-5. PubMed ID: 3997830
[TBL] [Abstract][Full Text] [Related]
12. A common NH53K mutation in the combining site of antibodies raised against chlamydial LPS glycoconjugates significantly increases avidity.
Blackler RJ; Müller-Loennies S; Brooks CL; Evans DW; Brade L; Kosma P; Brade H; Evans SV
Biochemistry; 2011 Apr; 50(16):3357-68. PubMed ID: 21405106
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into parallel strategies for germline antibody recognition of lipopolysaccharide from Chlamydia.
Evans DW; Müller-Loennies S; Brooks CL; Brade L; Kosma P; Brade H; Evans SV
Glycobiology; 2011 Aug; 21(8):1049-59. PubMed ID: 21543444
[TBL] [Abstract][Full Text] [Related]
14. Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.
Thomson CA; Bryson S; McLean GR; Creagh AL; Pai EF; Schrader JW
EMBO J; 2008 Oct; 27(19):2592-602. PubMed ID: 18772881
[TBL] [Abstract][Full Text] [Related]
15. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4.
Bundle DR; Eichler E; Gidney MA; Meldal M; Ragauskas A; Sigurskjold BW; Sinnott B; Watson DC; Yaguchi M; Young NM
Biochemistry; 1994 May; 33(17):5172-82. PubMed ID: 7513555
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided antibody design.
Kuroda D; Shirai H; Jacobson MP; Nakamura H
Protein Eng Des Sel; 2012 Oct; 25(10):507-21. PubMed ID: 22661385
[TBL] [Abstract][Full Text] [Related]
18. Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognition.
de Haard H; Kazemier B; van der Bent A; Oudshoorn P; Boender P; Arends JW; van Gemen B
Immunotechnology; 1999 Mar; 4(3-4):203-15. PubMed ID: 10231090
[TBL] [Abstract][Full Text] [Related]
19. Molecular and structural basis for Lewis glycan recognition by a cancer-targeting antibody.
Soliman C; Guy AJ; Chua JX; Vankemmelbeke M; McIntosh RS; Eastwood S; Truong VK; Elbourne A; Spendlove I; Durrant LG; Ramsland PA
Biochem J; 2020 Sep; 477(17):3219-3235. PubMed ID: 32789497
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional model of the BR96 monoclonal antibody variable fragment.
Bajorath J
Bioconjug Chem; 1994; 5(3):213-9. PubMed ID: 7522581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
